Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in vivo atherosclerosis imaging.

Paeng JC, Lee YS, Lee JS, Jeong JM, Kim KB, Chung JK, Lee DS.

Ann Nucl Med. 2013 Nov;27(9):847-54. doi: 10.1007/s12149-013-0757-x. Epub 2013 Aug 6.

PMID:
23918450
2.

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.

Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, Lee DS, Chung JK, Lee MC.

J Nucl Med. 2008 May;49(5):830-6. doi: 10.2967/jnumed.107.047423. Epub 2008 Apr 15.

3.

MicroPET/CT imaging of αvβ₃ integrin via a novel ⁶⁸Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction.

Menichetti L, Kusmic C, Panetta D, Arosio D, Petroni D, Matteucci M, Salvadori PA, Casagrande C, L'Abbate A, Manzoni L.

Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1265-74. doi: 10.1007/s00259-013-2432-9. Epub 2013 May 15.

PMID:
23674206
4.

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.

Li ZB, Chen K, Chen X.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1100-8. doi: 10.1007/s00259-007-0692-y. Epub 2008 Jan 19.

PMID:
18204838
5.

PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine.

Israel I, Richter D, Stritzker J, van Ooschot M, Donat U, Buck AK, Samnick S.

Curr Cancer Drug Targets. 2014;14(4):371-9.

PMID:
24720338
6.

Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET: characterization and application to therapeutic efficacy monitoring in rats.

Eo JS, Paeng JC, Lee S, Lee YS, Jeong JM, Kang KW, Chung JK, Lee DS.

Coron Artery Dis. 2013 Jun;24(4):303-11. doi: 10.1097/MCA.0b013e3283608c32.

PMID:
23542160
7.

[68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.

Knetsch PA, Petrik M, Griessinger CM, Rangger C, Fani M, Kesenheimer C, von Guggenberg E, Pichler BJ, Virgolini I, Decristoforo C, Haubner R.

Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1303-12. doi: 10.1007/s00259-011-1778-0. Epub 2011 Apr 13.

PMID:
21487838
8.

(68)Ga small peptide imaging: comparison of NOTA and PCTA.

Ferreira CL, Yapp DT, Mandel D, Gill RK, Boros E, Wong MQ, Jurek P, Kiefer GE.

Bioconjug Chem. 2012 Nov 21;23(11):2239-46. doi: 10.1021/bc300348d. Epub 2012 Oct 19.

PMID:
23035991
9.

Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging.

Kim JH, Lee JS, Kang KW, Lee HY, Han SW, Kim TY, Lee YS, Jeong JM, Lee DS.

Cancer Biother Radiopharm. 2012 Feb;27(1):65-71. doi: 10.1089/cbr.2011.1061. Epub 2011 Dec 9.

PMID:
22149685
10.

(68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.

Liu Z, Niu G, Wang F, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Sep;36(9):1483-94. doi: 10.1007/s00259-009-1123-z. Epub 2009 Apr 10.

PMID:
19360404
11.

[⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.

Knetsch PA, Petrik M, Rangger C, Seidel G, Pietzsch HJ, Virgolini I, Decristoforo C, Haubner R.

Nucl Med Biol. 2013 Jan;40(1):65-72. doi: 10.1016/j.nucmedbio.2012.09.006. Epub 2012 Oct 26.

PMID:
23102540
12.

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.

Yoon HJ, Kang KW, Chun IK, Cho N, Im SA, Jeong S, Lee S, Jung KC, Lee YS, Jeong JM, Lee DS, Chung JK, Moon WK.

Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1534-43. doi: 10.1007/s00259-014-2744-4. Epub 2014 Mar 21.

PMID:
24652232
13.

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.

Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X.

Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):947-57. doi: 10.1007/s00259-008-1045-1. Epub 2009 Jan 22.

PMID:
19159928
14.

One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.

Liu S, Liu H, Jiang H, Xu Y, Zhang H, Cheng Z.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1732-41. doi: 10.1007/s00259-011-1847-4. Epub 2011 May 27.

15.

In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).

Máté G, Kertész I, Enyedi KN, Mező G, Angyal J, Vasas N, Kis A, Szabó É, Emri M, Bíró T, Galuska L, Trencsényi G.

Eur J Pharm Sci. 2015 Mar 10;69:61-71. doi: 10.1016/j.ejps.2015.01.002. Epub 2015 Jan 13.

PMID:
25592229
16.

Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.

Liu Z, Li ZB, Cao Q, Liu S, Wang F, Chen X.

J Nucl Med. 2009 Jul;50(7):1168-77. doi: 10.2967/jnumed.108.061739. Epub 2009 Jun 12.

17.

A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.

Pan D, Xu YP, Yang RH, Wang L, Chen F, Luo S, Yang M, Yan Y.

Amino Acids. 2014 Jun;46(6):1481-9. doi: 10.1007/s00726-014-1718-y. Epub 2014 Mar 17.

PMID:
24633452
18.

Preparation of Ga-68-NOTA as a renal PET agent and feasibility tests in mice.

Lee JY, Jeong JM, Kim YJ, Jeong HJ, Lee YS, Lee DS, Chung JK.

Nucl Med Biol. 2014 Feb;41(2):210-5. doi: 10.1016/j.nucmedbio.2013.11.005. Epub 2013 Dec 1.

PMID:
24388044
19.

⁶⁸Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection.

Vilche M, Reyes AL, Vasilskis E, Oliver P, Balter H, Engler H.

J Nucl Med. 2016 Apr;57(4):622-7. doi: 10.2967/jnumed.115.161265. Epub 2016 Jan 14.

20.

Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.

Yu HM, Chen JH, Lin KL, Lin WJ.

J Labelled Comp Radiopharm. 2015 Jun 15;58(7):299-303. doi: 10.1002/jlcr.3296. Epub 2015 May 21.

PMID:
25997858

Supplemental Content

Support Center